These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32341983)

  • 1. β-Amyloid precursor protein (APP) and the human diseases.
    Nguyen KV
    AIMS Neurosci; 2019; 6(4):273-281. PubMed ID: 32341983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulation in Amyloid Precursor Protein with Genomic Rearrangements and the Lesch-Nyhan Syndrome.
    Nguyen KV
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(10):674-90. PubMed ID: 26398526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of various APP-mRNA isoforms and epistasis in Lesch-Nyhan disease.
    Nguyen KV; Nyhan WL
    Neurosci Lett; 2017 Mar; 643():52-58. PubMed ID: 28192196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human β-amyloid precursor protein: biomolecular and epigenetic aspects.
    Nguyen KV
    Biomol Concepts; 2015 Mar; 6(1):11-32. PubMed ID: 25719338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation in amyloid precursor protein and the Lesch-Nyhan syndrome.
    Nguyen KV
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1091-5. PubMed ID: 24680827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential molecular link between the β-amyloid precursor protein (APP) and hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme in Lesch-Nyhan disease and cancer.
    Nguyen KV
    AIMS Neurosci; 2021; 8(4):548-557. PubMed ID: 34877405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesch-Nyhan disease: I. Construction of expression vectors for hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme and amyloid precursor protein (APP).
    Nguyen KV; Naviaux RK; Nyhan WL
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(6):905-922. PubMed ID: 32312153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalomalacia/gliosis, deep venous thrombosis, and cancer in Arg393His antithrombin Hanoi and the potential impact of the β-amyloid precursor protein (APP) on thrombosis and cancer.
    Nguyen KV
    AIMS Neurosci; 2022; 9(2):175-215. PubMed ID: 35860682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Amyloid-β Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-β Production.
    Chang JL; Hinrich AJ; Roman B; Norrbom M; Rigo F; Marr RA; Norstrom EM; Hastings ML
    Mol Ther; 2018 Jun; 26(6):1539-1551. PubMed ID: 29628304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.
    Westmark CJ; Sokol DK; Maloney B; Lahiri DK
    Mol Psychiatry; 2016 Oct; 21(10):1333-41. PubMed ID: 27573877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiology and pharmacology of amyloid precursor protein.
    Cho Y; Bae HG; Okun E; Arumugam TV; Jo DG
    Pharmacol Ther; 2022 Jul; 235():108122. PubMed ID: 35114285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
    Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
    Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
    Volloch V; Olsen B; Rits S
    Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting apolipoprotein E and N-terminal amyloid β-protein precursor interaction improves cognition and reduces amyloid pathology in Alzheimer's mice.
    Sawmiller D; Koyama N; Fujiwara M; Segawa T; Maeda M; Mori T
    J Biol Chem; 2023 Jul; 299(7):104846. PubMed ID: 37211092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
    Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
    Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy.
    Joshi G; Gan KA; Johnson DA; Johnson JA
    Neurobiol Aging; 2015 Feb; 36(2):664-79. PubMed ID: 25316599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mechanism for beta-amyloid overproduction in Alzheimer's disease: precursor-independent generation of beta-amyloid via antisense RNA-primed mRNA synthesis.
    Volloch V
    FEBS Lett; 1996 Jul; 390(2):124-8. PubMed ID: 8706841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer's disease and normal physiology.
    Pfundstein G; Nikonenko AG; Sytnyk V
    Front Cell Dev Biol; 2022; 10():969547. PubMed ID: 35959488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2020; 2(1):75-89. PubMed ID: 32201863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.